Journal articles on the topic 'The pharmaceutical enterprise'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'The pharmaceutical enterprise.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Shabelnyk, Tetiana V. "The Method of Hierarchy Analysis as a Mechanism for Choosing a Development Strategy for a Pharmaceutical Enterprise." Business Inform 9, no. 548 (2023): 117–22. http://dx.doi.org/10.32983/2222-4459-2023-9-117-122.
Full textWedha, Bayu Yas, Michael Sagar Vasandani, and Alessandro Enriqco Putra Bayu Wedha. "Innovative Role of Blockchain Pharmaceutical Supply Chain Digital Transformation: Enterprise Architecture Perspective." sinkron 8, no. 4 (2023): 2490–500. http://dx.doi.org/10.33395/sinkron.v8i4.13043.
Full textLi, Jian Jun. "The Empirical Analysis of Small and Medium Sized Pharmaceutical Enterprises Operating Performance and Debt Source Structure." Applied Mechanics and Materials 496-500 (January 2014): 2872–75. http://dx.doi.org/10.4028/www.scientific.net/amm.496-500.2872.
Full textLisna, Anastasiіа, Olga Posilkina, Elena Litvinova, Yuliia Bratishko, and Olga Gladkova. "Methodological approaches to assessing digital maturity of logistics activities of pharmaceutical enterprises." ScienceRise: Pharmaceutical Science, no. 4(44) (August 31, 2023): 76–88. http://dx.doi.org/10.15587/2519-4852.2023.286741.
Full textCavalla, David. "The extended pharmaceutical enterprise." Drug Discovery Today 8, no. 6 (2003): 267–74. http://dx.doi.org/10.1016/s1359-6446(03)02634-5.
Full textCai, Yating. "Comparison of R&D information disclosure of Chinese and foreign listed pharmaceutical enterprises – Take Hengrui Pharmaceutical and Pfizer Pharmaceutical as examples." SHS Web of Conferences 170 (2023): 02021. http://dx.doi.org/10.1051/shsconf/202317002021.
Full textDemchenko, Nataliia V., Iryna A. Popova, Natalia Ye Lelyuk, and Alina B. Shved. "The Instruments and Ways to Ensure Economic Security of Pharmaceutical Enterprises." PROBLEMS OF ECONOMY 2, no. 56 (2023): 147–55. http://dx.doi.org/10.32983/2222-0712-2023-2-147-155.
Full textHuang, Zhe, Yipeng Lan, and Xiangqi Zha. "Research on government subsidy strategies for new drug R&D considering spillover effects." PLOS ONE 17, no. 2 (2022): e0262655. http://dx.doi.org/10.1371/journal.pone.0262655.
Full textLin, Chun Cai, and Yan Peng He. "Study on the Pharmaceutical Distribution Enterprise IT Adoption Influencing Factors Model." Applied Mechanics and Materials 548-549 (April 2014): 1947–53. http://dx.doi.org/10.4028/www.scientific.net/amm.548-549.1947.
Full textYang, Jingyuan, Ling Wang, Ziyuan Sun, Fangming Zhu, Yihui Guo, and Yan Shen. "Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model." International Journal of Environmental Research and Public Health 18, no. 21 (2021): 11560. http://dx.doi.org/10.3390/ijerph182111560.
Full textNatali, Zakharko, Sahaidak-Nikitiuk Rita, and Demchenko Nataliya. "METHODOLOGY FOR ASSESSING THE LOGISTICS POTENTIAL OF THE FOREIGN ECONOMIC ACTIVITY OF A PHARMACEUTICAL COMPANY." EUREKA: Health Sciences 5 (September 30, 2019): 27–33. https://doi.org/10.21303/2504-5679.2019.00997.
Full textZakharko, Natali, Rita Sahaidak-Nikitiuk, and Nataliya Demchenko. "METHODOLOGY FOR ASSESSING THE LOGISTICS POTENTIAL OF THE FOREIGN ECONOMIC ACTIVITY OF A PHARMACEUTICAL COMPANY." EUREKA: Health Sciences 5 (September 20, 2019): 27–33. http://dx.doi.org/10.21303/2504-5679.2019.00997.
Full textCherniavskyi, Andrii, Daryna Tarasenko, Vitalii Nikitiuk, Rita Sahaidak-Nikitiuk, and Nataliia Demchenko. "Method approaches to assessing the adaptation potential of the industrial pharmaceutical enterprise to changing economic conditions." ScienceRise: Pharmaceutical Science, no. 5(45) (October 31, 2023): 90–98. http://dx.doi.org/10.15587/2519-4852.2023.290171.
Full textKovalenko, Svitlana, Elena Litvinova, Elena Tkachenko, and Tatyana Dyadyun. "DEVELOPMENT OF THE "CONFORMITY ASSESSMENT" METHODOLOGY WITHIN THE QUALITYMANAGEMENT SYSTEM AT A PHARMACEUTICAL ENTERPRISE." Bulletin of the National Technical University "Kharkiv Polytechnic Institute" (economic sciences), no. 2 (April 7, 2021): 3–7. http://dx.doi.org/10.20998/2519-4461.2021.2.3.
Full textUSMANOV, B. I., S. M. GORYUNOVA, and A. F. KARIMOVA. "PROBLEMS OF PHARMACEUTICAL PRODUCTION." Herald of Technological University 27, no. 5 (2024): 122–27. http://dx.doi.org/10.55421/1998-7072_2024_27_5_122.
Full textDranus, V. V. "Evaluation of the Effectiveness of Management of Financial Resources of Pharmaceutical Enterprises." Modern Economics 36, no. 1 (2022): 51–58. http://dx.doi.org/10.31521/modecon.v36(2022)-08.
Full textHuang, Zhenyi, Changrong Li, and Chenbo Luo. "A Study on Financial Risk Early Warning in Pharmaceutical Companies: The Case of Ruikang Pharmaceutical." Highlights in Business, Economics and Management 43 (December 5, 2024): 237–44. https://doi.org/10.54097/8q2vwr78.
Full textKumar, Gaurav. "Blockchain in Enterprise Application for Pharmaceutical Drug Traceability." International Journal of Science and Research (IJSR) 12, no. 8 (2023): 130–34. http://dx.doi.org/10.21275/sr23730073350.
Full textChen, Zhehao. "Enterprise Valuation Study: Taking Betta Pharmaceuticals as Evidence." BCP Business & Management 38 (March 2, 2023): 2520–28. http://dx.doi.org/10.54691/bcpbm.v38i.4134.
Full textGarmatiuk, Olena. "Evaluation of business profitability indicators as an indicator of the efficiency of sales activities of pharmaceutical enterprises." Ukrainian Journal of Applied Economics and Technology 8, no. 1 (2023): 174–79. http://dx.doi.org/10.36887/2415-8453-2023-1-25.
Full textPROKOPOVA, Olena. "Management reporting of pharmaceutical enterprises." SCIENTIA FRUCTUOSA 149, no. 3 (2023): 112–20. http://dx.doi.org/10.31617/1.2023(149)09.
Full textBenaouag, Charaf Eddine Amine, and Lazhar Kharchi. "Technological innovation and its role in promoting the competitive advantage of the industrial enterprises." Journal of Innovations and Sustainability 8, no. 2 (2024): 12. http://dx.doi.org/10.51599/is.2024.08.02.12.
Full textYi Yang. "Research on the Impact of ESG Information Disclosure on the Value of Pharmaceutical Manufacturing Enterprises-- Empirical Evidence from A-share Listed Companies." Journal of Information Systems Engineering and Management 10, no. 16s (2025): 617–38. https://doi.org/10.52783/jisem.v10i16s.2650.
Full textChen, Lixin. "Research on the Path of Chinese Pharmaceutical Enterprises Going Public based on the Comprehensive Registration System." Highlights in Business, Economics and Management 15 (June 28, 2023): 216–24. http://dx.doi.org/10.54097/hbem.v15i.9350.
Full textShi, Bingxiao, Chunlan Mou, Yiwen Zhang, and Tiantian Cui. "Different paths, same destination, yet diverse effects: Antecedent configurations and performance implications of digital transformation in pharmaceutical manufacturing enterprises——Evidence from Chinese listed companies." PLOS One 20, no. 5 (2025): e0323130. https://doi.org/10.1371/journal.pone.0323130.
Full textXiaoming Deng, Yande Wang, Hui Chen, Xiang Zhou, Wei Xie,. "Assessing Audit Risks in Enterprises on the Growth Enterprise Market: A Grounded Theory Approach." Journal of Electrical Systems 20, no. 4s (2024): 287–96. http://dx.doi.org/10.52783/jes.1914.
Full textHaider, Rehan. "Innovation and Marketing in the Pharmaceutical Industry." Journal of Clinical Case Reports & Studies 5, no. 3 (2024): 01–09. http://dx.doi.org/10.31579/2690-8808/195.
Full textWang, Fang, and Norma G. Nunez. "Research on Operational Model Optimization of X Pharmaceutical Group Under Digital Transformation." International Journal of Emerging Technologies and Advanced Applications 1, no. 11 (2024): 1–12. https://doi.org/10.62677/ijetaa.2411129.
Full textNaveen Rajora. "Essence controls in pharmaceutical enterprise systems." International Journal of Science and Research Archive 8, no. 2 (2023): 012–17. http://dx.doi.org/10.30574/ijsra.2023.8.2.0197.
Full textLan, Yipeng, Chenlu Meng, Lihua Sun, and Zhe Huang. "Coping with drug shortages: A study of government-enterprise option cooperation stockpiling strategies for drugs in shortage considering API surrogate stockpiling subsidies." PLOS ONE 19, no. 7 (2024): e0305383. http://dx.doi.org/10.1371/journal.pone.0305383.
Full textShinkevich, A. I., L. R. Mukhamatgaleeva, and V. I. Bobkov. "THE ROLE OF THE INTRODUCTION OF DIGITAL PRODUCTION SYSTEMS IN A PHARMACEUTICAL ENTERPRISE." Izvestiya of Samara Scientific Center of the Russian Academy of Sciences 23, no. 6 (2021): 62–66. http://dx.doi.org/10.37313/1990-5378-2021-23-6-62-66.
Full textSAHAIDAK-NIKITIUK, Rita, Bogdan KOPTEV, Dmytriy ZORIN, and Natalia ZAKHARKO. "CONCEPTUAL APPROACHES TO THE PROCESS OF FORMING AN ORGANIZATIONAL AND ECONOMIC MECHANISM FOR MANAGING FOREIGN ECONOMIC ACTIVITY OF A MANUFACTURING PHARMACEUTICAL ENTERPRISE ON THE BASIS OF LOGISTICS." Economic Synergy, no. 4 (December 27, 2022): 10–20. http://dx.doi.org/10.53920/es-2022-4-1.
Full textChen, Zefei, Bowen Duan, Ailin Shen, and Yucheng Yan. "Research on the Development Status and Problems of Scientific and Technological Small and Medium-Sized Enterprises." BCP Business & Management 23 (August 4, 2022): 466–75. http://dx.doi.org/10.54691/bcpbm.v23i.1387.
Full textKuznyetsova, Anzhela, Damir Kulish, Borys Prykhodko, and Oleksandr Kuznyetsov. "Innovative Approaches to Improving the Process of Risk Management in the Context of Developing a Strategy for the Foreign Economic Activity of Enterprises." Marketing and Management of Innovations 15, no. 1 (2024): 210–28. http://dx.doi.org/10.21272/mmi.2024.1-16.
Full textRomanova, E. R., and V. S. Stel’makh. "Strategy of crisis management of the pharmaceutical industry in the Republic of Sakha (Yakutiya)." Vestnik Universiteta, no. 3 (April 12, 2019): 44–48. http://dx.doi.org/10.26425/1816-4277-2019-3-44-48.
Full textTerenteva, Natalya, and Julia Matyush. "INNOVATIVE MARKETING AS A CONDITION FOR THE DEVELOPMENT OF PHARMACEUTICAL INDUSTRY ENTERPRISES IN THE CONTEXT OF DIGITALIZATION." Actual Problems of Economics 1, no. 267 (2023): 49–56. http://dx.doi.org/10.32752/1993-6788-2023-1-267-49-56.
Full textFrolova, Elena D., Zulparuza A. Abdurahkmanova, and Alexander A. Ishukov. "Participation of Kazakhstan Pharmaceutical Companies in Global Value Chains Authors." Economy of Region 17, no. 2 (2021): 473–85. http://dx.doi.org/10.17059/ekon.reg.2021-2-9.
Full textPopova, Iryna A., and Maryna Yu Gliznutsa. "A Methodology for Assessing the Efficiency of Innovative Activities of a Pharmaceutical Enterprise." Business Inform 1, no. 564 (2025): 120–28. https://doi.org/10.32983/2222-4459-2025-1-120-128.
Full textLupak, Ruslan, Marta Kunytska-Iliash, Yaroslav Berezivskyi, Natalia Nakonechna, Liliya Ivanova, and Taras Vasyltsiv. "Information and analytical support system of enterprise competitiveness management." Accounting 7, no. 7 (2021): 1785–98. http://dx.doi.org/10.5267/j.ac.2021.4.018.
Full textLisna, Anastasiia, Olga Posilkina, and Olena Litvinova. "Digital logistics as a tool for minimizing logistics risks in the activities of pharmaceutical enterprises." Annals of Mechnikov Institute, no. 2 (June 13, 2024): 13–18. https://doi.org/10.5281/zenodo.11634418.
Full textXing, Haodong. "Review of Research Methods on the Relationship between Enterprise Green Development Construction and Pharmaceutical Project Performance under the Background of Dual Carbon." Applied Science and Innovative Research 9, no. 2 (2025): p13. https://doi.org/10.22158/asir.v9n2p13.
Full textZhurenko, Victoria V., and Viacheslav O. Lebedynets. "Characteristics of development and dissemination of environmental management systems in the area of production of medicines in Ukraine." Česká a slovenská farmacie 71, no. 5 (2022): 200–213. http://dx.doi.org/10.5817/csf2022-5-200.
Full textRogachev, Andrey Y. "Enterprise Risk Management In a Pharmaceutical Company." Risk Management 10, no. 1 (2008): 76–84. http://dx.doi.org/10.1057/palgrave.rm.8250037.
Full textShi, Shengyi, Guangping Wang, Yanfei Huo, Baxian Yi, and Xiaoming Wu. "Study on Innovation Behavior of State-owned Pharmaceutical Enterprises Based on the Viewpoint of Ownership Structure Reforming." Journal of Politics and Law 9, no. 9 (2016): 195. http://dx.doi.org/10.5539/jpl.v9n9p195.
Full textVasilica, RUSU. "ASSESSMENT OF UNCERTAINTY WHILE SELECTING THE OPERATIONAL STRATEGY BY THE INDUSTRIAL ENTERPRISES IN ROMANIA." ECONOMY AND SOCIOLOGY 2019 NO. 1, no. 2021.1 (July 1, 2021): 75–86. http://dx.doi.org/10.36004/nier.es.2021.1-07.
Full textSas, Liudmyla, Roman Hvozdyk, and Mykola Mykhailiuk. "Prospects for the development of pharmaceutical industry enterprises' activities." Market Relations Development in Ukraine 119, no. 11(282) (2025): 57–62. https://doi.org/10.5281/zenodo.14825059.
Full textAliyev, A. G., R. O. Shahverdiyeva, and S. A. Salimkhanova. "Issues of Development of the Information Support System of Innovative Enterprises Based on Modern Digital Platforms." Informacionnye Tehnologii 29, no. 7 (2023): 374–81. http://dx.doi.org/10.17587/it.29.374-381.
Full textChitta, Shyamsunder, Ravi Kumar Jain, and Bhimaraya E. Metri. "Funding Landscape and Gap Analysis for Pharmaceutical MSMEs in Hyderabad." SEDME (Small Enterprises Development, Management & Extension Journal): A worldwide window on MSME Studies 47, no. 1 (2020): 7–16. http://dx.doi.org/10.1177/0970846420930443.
Full textChang, Qi Zhi, Zhang You Hu, Xiao Hui Weng, and Li Ding. "Pharmaceutical Companies SaaS Cloud Services Management Platform Based Design and Application." Advanced Materials Research 1030-1032 (September 2014): 1913–18. http://dx.doi.org/10.4028/www.scientific.net/amr.1030-1032.1913.
Full textKUBOTA, KIYOSHI. "Present situations of side effect " enterprise reports" and recognition of enterprises on open problems of enterprise reports. Questionnairing results for 96 pharmaceutical enterprises." Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics 29, no. 1/2 (1998): 49–50. http://dx.doi.org/10.3999/jscpt.29.49.
Full text